Clinical studies of cyclazocine in the treatment of narcotic addiction.
D000293:Adolescent; D000328:Adult; D000368:Aged; D000700:Analgesics / Q000009:adverse effects / Q000627:therapeutic use*; D001392:Azocines / Q000009:adverse effects / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003496:Cyclazocine / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D004569:Electroencephalography; D003932:Heroin / Q000037:antagonists & inhibitors; D006801:Humans; D007275:Injections, Intravenous; D007398:Interpersonal Relations; D008297:Male; D008875:Middle Aged; D009292:Narcotic Antagonists / Q000009:adverse effects / Q000627:therapeutic use*; D012725:Sexual Behavior; D019966:Substance-Related Disorders / Q000188:drug therapy* / Q000534:rehabilitation
D000700:Analgesics; D001392:Azocines; D009292:Narcotic Antagonists; D003932:Heroin; D003496:Cyclazocine